{"id":"W4310119573","doi":"10.1182/blood-2022-157060","title":"Assessing the Burden of Adverse Events in a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia (CLL)","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Ibrutinib; Adverse effect; Internal medicine; Chronic lymphocytic leukemia; Incidence (geometry); Post-hoc analysis; Oncology; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001834542,0.0002965184,0.0009067186,0.0005428678,0.00009708396,0.000006483138,0.0006335548,0.0001537658,0.0002495237],"category_scores_gemma":[0.0009846983,0.0002460562,0.000236929,0.001941604,0.0001638989,0.000113516,0.0005579879,0.0006070884,0.00001959848],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.05349098,"about_ca_system_score_gemma":0.04112964,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01673902,"about_ca_topic_score_gemma":0.0005608516,"domain_scores_codex":[0.9954594,0.0006361758,0.001160936,0.0005747105,0.001347694,0.000821033],"domain_scores_gemma":[0.997611,0.000834628,0.000316624,0.0009540839,0.00009779859,0.0001858523],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6030307,0.01563388,0.02651372,0.006852983,0.003655724,0.005251096,0.03987797,0.1746646,0.09159327,0.0003048154,0.0008391406,0.03178214],"study_design_scores_gemma":[0.9485171,0.005511784,0.006070336,0.00103404,0.0004514953,0.0001747101,0.002219726,0.02649765,0.008499185,0.00002526494,0.0006541171,0.000344625],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948916,0.0005024585,0.000001788521,0.0001505735,0.0002310826,0.00292036,0.00001564092,0.00003748634,0.001248947],"genre_scores_gemma":[0.9988375,0.00005339185,0.00007943015,0.00003583359,0.0002329278,0.0003591659,0.00003786655,0.00005664612,0.0003072298],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3454864,"threshold_uncertainty_score":0.9999992,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04978422610707629,"score_gpt":0.3696547688485834,"score_spread":0.3198705427415072,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}